Table 2.
CT features of 25 COVID-19 patients
| CT findings | Group 1 (13) | Group 2 (16) | Group 3 (3) |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Unilateral lung | 4 (30.7) | 1 (6.3) | 0 (0.0) |
| Bilateral lungs | 9 (69.2) | 15 (93.7) | 3 (100.0) |
| One lobe | 4 (30.7) | 1 (6.3) | 0 (0.0) |
| Two lobes | 4 (30.7) | 2 (12.5) | 0 (0.0) |
| Three lobes | 0 (0.0) | 1 (6.3) | 0 (0.0) |
| More than three lobes | 5 (38.5) | 12 (75.0) | 3 (100.0) |
| Region of lobes | |||
| Upper | 6 (46.1) | 14 (87.5) | 3 (100.0) |
| Middle | 5 (38.5) | 13 (81.3) | 3 (100.0) |
| Lower | 11 (84.6) | 15 (93.7) | 3 (100.0) |
| Distribution | |||
| Anterior | 5 (38.5) | 10 (62.5) | 1 (33.3) |
| Posterior | 12 (92.3) | 15 (93.7) | 3 (100.0) |
| Peripheral | 13 (100.0) | 16 (100.0) | 3 (100.0) |
| Central | 0 (0.0) | 1 (6.3) | 0 (0.0) |
| Lesions | |||
| GGO only | 7 (53.8) | 5 (31.3) | 0 (0.0) |
| GGO with reticular and/or interlobular septal thickening | 1(7.7) | 2 (12.5) | 0 (0.0) |
| GGO with consolidation | 6 (46.1) | 8 (50.0) | 3 (100.0) |
| Air bronchogram | 8 (61.5) | 3 (18.8) | 2 (66.7) |
| Bronchial wall thickening | 1 (7.7) | 6 (37.6) | 1 (33.3) |
| Reticular shadow | 4 (30.7) | 2 (12.5) | 1 (33.3) |
| CT halo | 4 (30.7) | 6 (37.6) | 0 (0.0) |
| Reversed halo sign | 1 (7.7) | 0 (0.0) | 0 (0.0) |
| Pericardial | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Nodules | 0 (0.0) | 1 (6.3) | 0 (0.0) |
| Pleural effusion | 0 (0.0) | 1 (6.3) | 1 (33.3) |
| Lymphadenopathy | 0 (0.0) | 0 (0.0) | 0 (0.0) |